TFRC and acute lymphoblastic leukemia: Intriguingly, each PDX model additionally revealed unique dropout genes, such as CD79A in ALL-199 or TFRC in ALL-265 (Figs. 2C and S6), suggesting a capacity of the screening approach to detect patient sample-specific dependencies.